Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile.
You can purchase shares of Applied Therapeutics (NASDAQ:APLT) through any online brokerage.
Other companies in Applied Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Gain Therapeutics (NASDAQ:GANX), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
Applied Therapeutics has a consensus price target of $5.46.
The stock price for Applied Therapeutics (NASDAQ: APLT) is $0.5447 last updated February 21, 2025 at 7:51 PM EST.
There are no upcoming dividends for Applied Therapeutics.
Applied Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Applied Therapeutics.
Applied Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.